NASDAQ:VTL - Nasdaq -
0.83
+0.06 (+7.78%)
The current stock price of VTL is 0.83 null. In the past month the price increased by 300.19%. In the past year, price decreased by -85.93%.
Vital Therapies, Inc. is a biotherapeutic company. It is focused on developing a cell-based therapy targeting the treatment of acute liver failure. The Company operates in the United States, Europe, and China. Vital Therapies, Inc. is based in San Diego, California.
VITAL THERAPIES INC
15222-B AVENUE OF SCIENCE
SAN DIEGO CA 92128
CEO: Duane D. Nash
Phone: 858-673-6840
The current stock price of VTL is 0.83 null. The price increased by 7.78% in the last trading session.
The exchange symbol of VITAL THERAPIES INC is VTL and it is listed on the Nasdaq exchange.
VTL stock is listed on the Nasdaq exchange.
VITAL THERAPIES INC (VTL) has a market capitalization of 35.17M null. This makes VTL a Nano Cap stock.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VTL does not pay a dividend.
VITAL THERAPIES INC (VTL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.89).
ChartMill assigns a technical rating of 7 / 10 to VTL. When comparing the yearly performance of all stocks, VTL is one of the better performing stocks in the market, outperforming 98.28% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to VTL. The financial health of VTL is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months VTL reported a non-GAAP Earnings per Share(EPS) of -0.89. The EPS increased by 32.06% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -348.98% | ||
ROE | -404.24% | ||
Debt/Equity | 0 |